CD4+CD45RO+ T cells in the lesional blood highly expressed genes relating to cancer progression and CTCL pathogenesis: RGS1, RDH10, HES1, DNAH9, ANK2, and SGK1 (Fig. 3a)16–25. This evidence concerns the gene DNAH9 and primary cutaneous T-cell non-Hodgkin lymphoma.